Table 2

Levels of biomarkers before, 3, 6, 24 and 48 h after application of SIRT

Reference value (95th perc. of healthy)

0 hours

3 hours

6 hours

24 hours

48 hours

Median

Median

Median

Median

Median

Range

Range

Range

Range

Range


Nucleo-somes [ng/mL]

190.5

197.6

237.4

758.5

596.0

< 36

5.0-1624

34.8-2501

40.7-2064

21.7-4334

51.7-2547


CYFRA 21-1

[ng/mL]

10.9

9.3

8.8

28.6

27.5

< 2.2

0.8-246.0

0.9-240.0

1.1-230.0

1.0-811.0

1.5-638.0


CEA

[ng/mL]

330.0

343.5

356.5

351.0

433.0

< 3.4

2.0-31620

1.9-33010

1.9-16980

1.6-36120

1.6-37550


CA 19-9 [U/mL]

40.0

41.6

49.7

48.7

56.4

< 37

2.4-11530

2.3-24400

2.2-8748

2.4-18550

2.3-17000


LDH

[U/L]

407.0

486.5

585.0

< 250

178.0-3068

143.0-2923

142.0-3585


CRP

[mg/dL]

1.3

1.3

4.6

< 0.5

0.1-20.3

1.3-21.8

0.1-16.3


CHE

[kU/L]

7.3

6.3

5.9

5.0-13.3

2.8-11.1

2.8-11.1

5.9-10.5


AST

[U/L]

52.0

74.5

68.5

< 33

24.0-190.0

15.0-339.0

19.0-317.0


ALT

[U/L]

34.5

46.0

48.5

< 35

15.0-268.0

14.0-178.0

13.0-136.0


Bilirubin

[mg/dL]

0.7

1.0

1.2

< 1.0

0.3-1.9

0.4-2.2

0.4-2.8


AP

[U/L]

160.0

148.0

156.0

< 135

81.0-742.0

63.0-655.0

61.0-630.0


GGT

[U/L]

183.5

165.5

168.5

< 38

33.0-712.0

31.0-577.0

31.0-653.0


Amylase

[U/L]

58.0

44.0

46.5

< 100

20.0-136.0

20.0-429.0

20.0-519.0


Lipase

[U/L]

26.0

18.0

20.0

< 60

3.0-263.0

3.0-585.0

3.0-495.0


Fahmueller et al. BMC Cancer 2012 12:5   doi:10.1186/1471-2407-12-5

Open Data